Kodiak Sciences Future Growth
Future criteria checks 0/6
Kodiak Sciences's earnings are forecast to decline at 7% per annum while its annual revenue is expected to grow at 78.1% per year. EPS is expected to grow by 1% per annum.
Key information
-7.0%
Earnings growth rate
1.0%
EPS growth rate
Biotechs earnings growth | 0% |
Revenue growth rate | 78.1% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | N/A | -321 | -302 | N/A | 1 |
12/31/2025 | N/A | -222 | -197 | -135 | 3 |
12/31/2024 | N/A | -179 | -196 | -66 | 3 |
9/30/2024 | N/A | -192 | -147 | -119 | N/A |
6/30/2024 | N/A | -198 | -159 | -131 | N/A |
3/31/2024 | N/A | -233 | -176 | -147 | N/A |
12/31/2023 | N/A | -260 | -196 | -154 | N/A |
9/30/2023 | N/A | -271 | -197 | -177 | N/A |
6/30/2023 | N/A | -298 | -224 | -197 | N/A |
3/31/2023 | N/A | -309 | -252 | -211 | N/A |
12/31/2022 | N/A | -334 | -254 | -206 | N/A |
9/30/2022 | N/A | -357 | -263 | -210 | N/A |
6/30/2022 | N/A | -347 | -286 | -209 | N/A |
3/31/2022 | N/A | -312 | -266 | -191 | N/A |
12/31/2021 | N/A | -267 | -246 | -182 | N/A |
9/30/2021 | N/A | -220 | -208 | -150 | N/A |
6/30/2021 | N/A | -189 | -150 | -123 | N/A |
3/31/2021 | N/A | -159 | -114 | -100 | N/A |
12/31/2020 | N/A | -133 | -90 | -83 | N/A |
9/30/2020 | N/A | -102 | -70 | -68 | N/A |
6/30/2020 | N/A | -78 | -51 | -51 | N/A |
3/31/2020 | N/A | -64 | -50 | -50 | N/A |
12/31/2019 | N/A | -47 | -40 | -39 | N/A |
9/30/2019 | N/A | -46 | -37 | -36 | N/A |
6/30/2019 | N/A | -44 | -34 | -33 | N/A |
3/31/2019 | N/A | -41 | -26 | -25 | N/A |
12/31/2018 | N/A | -41 | -30 | -29 | N/A |
9/30/2018 | N/A | -38 | -26 | -26 | N/A |
6/30/2018 | N/A | -32 | N/A | -26 | N/A |
3/31/2018 | N/A | -31 | N/A | -25 | N/A |
12/31/2017 | N/A | -28 | N/A | -18 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KOD * is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KOD * is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KOD * is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KOD * is forecast to have no revenue next year.
High Growth Revenue: KOD * is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if KOD *'s Return on Equity is forecast to be high in 3 years time